patient view
This page is a research summary built from public sources (FDA, NIH, clinical trial registries). It is not medical advice.Always talk to your doctor about treatment decisions. Drug information here may be incomplete or out of date — verify with your prescriber and the manufacturer's package insert.
drug · small molecule
tivozanib
Phase 2updated 2mo agoby Kyowa Kirin Co Ltd🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for renal cell carcinoma and neoplasm and 10 investigational indications.
indications
indications
Diabetic Macular Edema
targets
Platelet-derived growth factor receptor betaVascular endothelial growth factor receptorMast/stem cell growth factor receptor Kit
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that